Digestive & Intestinal Remedies Market Size & Share 2024 – 2032

Digestive & Intestinal Remedies Market Size

Digestive And Intestinal Remedies Market size was valued at USD 19.5 billion in 2023 and is projected to grow at a CAGR of 3.5% from 2024 and 2032. The primary driver of this market's growth is the rising incidence of gastrointestinal disorders. Factors such as changing lifestyle habits, decreased physical activity, and shifts in dietary patterns have heightened the prevalence of digestive tract conditions.

Notably, the surge in processed food consumption has played a pivotal role in this trend. For example, data from the National Institutes of Health indicates that approximately 20% of the U.S. population is affected by GERD (Gastroesophageal Reflux Disease).
 

Another key driver is the increasing reliance on digital technologies, which, while making tasks less labor-intensive, have inadvertently led to reduced physical activity. This decline in activity is linked to chronic conditions, including obesity and various digestive issues. The World Health Organization reports that over 1 billion individuals worldwide grapple with obesity. Consequently, the rising obesity rates, combined with increasing instances of conditions like constipation, inflammatory bowel disease, gastroesophageal reflux disease, and irritable bowel syndrome, are poised to propel the digestive and intestinal remedies market in the coming years.
 

Digestive and intestinal remedies encompass a wide range of treatments, from medications and supplements to natural solutions, all aimed at addressing issues related to the digestive system and intestines. These remedies, which include laxatives, probiotics, antacids, anti-diarrheal medications, fiber supplements, antispasmodics, and digestive enzymes, are crafted to alleviate symptoms, enhance digestion, bolster gut health, and treat specific gastrointestinal (GI) tract conditions.
 

Digestive & Intestinal Remedies Market Trends

• The rising incidence of gastrointestinal diseases significantly drives the digestive and intestinal remedies market.
   
• For example, the Canadian Digestive Health Foundation reports that almost 17% of Canadian adults suffer from GERD. Symptoms reported include chest pain, chronic cough, heartburn, sleep apnea, regurgitation, and belching. Factors like a high intake of processed foods and being overweight contribute to this condition, leading to increased demand for digestive and intestinal remedies.
   
• Conditions such as Gastroesophageal Reflux Disease (GERD), irritable bowel syndrome (IBS), peptic ulcers, constipation, diarrhea, inflammatory bowel disease (IBD), and gastroenteritis often require remedies like digestive enzymes, anti-diarrheal medications, and fiber supplements, underscoring their importance in managing these ailments.
   
• As global cases of gastrointestinal conditions rise, so does the demand for effective treatments, driving market expansion.
   
• The over-the-counter availability of these remedies further boosts their adoption rate.
   

Digestive & Intestinal Remedies Market Analysis

Based on type, the market was segmented into three categories: digestive medicines, treatments for gastrointestinal complaints, and natural & synthetic agents. Dominating the market, the digestive medicines segment generated a revenue of USD 10.3 billion.
 

• Digestive medicines, which include both pharmaceutical and over-the-counter drugs, are specifically formulated to alleviate a range of digestive issues. These formulations effectively relieve symptoms such as heartburn, indigestion, bloating, constipation, and diarrhea.
   
• Many digestive medicines, like antacids and proton pump inhibitors (PPIs), are available over-the-counter, ensuring individuals can access them for immediate relief without needing a prescription.
   
• Furthermore, these medicines have undergone extensive research and have a long history of use, cementing their reputation for safety in both short-term and long-term applications.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on age group, the digestive & intestinal remedies market is segmented into adult and pediatric. In 2023, adults accounted for a dominant 89.9% share of the market, while the pediatric segment remained significantly smaller.
 

• Adult patients commonly experience gastrointestinal issues, partly because parents and healthcare providers exercise heightened caution regarding pediatric diet and health.
   
• Adults frequently face conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and inflammatory bowel disease (IBD). For instance, the National Institutes of Health reports that peptic ulcer disease impacts approximately 4 million individuals worldwide.
   
• Older adults often produce fewer digestive enzymes, complicating the breakdown of certain foods and leading to discomfort. As the digestive system slows with age, issues like constipation and indigestion become more prevalent, heightening the demand for remedies. Consequently, the growing geriatric population, combined with a high incidence of digestive issues in adults, is poised to propel this segment's growth in the coming years.
   

Based on distribution channels, the digestive & intestinal remedies market is segmented into offline and online. The online segment is anticipated to reach USD 6 billion by 2032.
 

• Online platforms empower consumers to buy digestive and intestinal remedies from home, sidestepping the need for a pharmacy visit. Operating 24/7, these platforms ensure remedies are accessible anytime, a boon for those facing symptoms outside regular hours.
   
• As the internet emerges as a primary health information source, consumers increasingly research digestive health issues and remedies online. This heightened awareness often influences their purchasing choices on digital platforms.
   
• Moreover, the surge in telemedicine and online consultations enables healthcare providers to prescribe digestive remedies, which patients can promptly purchase online, further fueling the market's growth.
   

In 2023, North America led the global digestive & intestinal remedies market, generating revenues of USD 8 billion, with projections to hit USD 10.8 billion by 2032.
 

• This regional leadership stems from heightened consumer awareness and a proactive approach to healthcare. Many consumers are turning to probiotics, fiber supplements, and digestive enzymes, aiming to uphold gut health and preempt potential issues.
   
• Furthermore, the rise in popularity of over-the-counter (OTC) digestive solutions—like antacids, laxatives, and anti-diarrheal medications—underscores a consumer trend towards seeking easily accessible symptom management.
   
• With heightened patient awareness and the convenience of both OTC and online purchasing, North America solidifies its top position in the global digestive & intestinal remedies arena.
   

In 2023, the U.S. accounted for a significant USD 7.4 billion share of the digestive & intestinal remedies market.
 

• Leading companies in the U.S. are prioritizing the development of advanced formulations, especially in areas like proton pump inhibitors (PPIs) and probiotics, emphasizing longer-lasting effects, reduced side effects, and enhanced efficacy. This focus is set to bolster the U.S. market.
   
• Moreover, platforms like social media, health blogs, and online forums are instrumental in enlightening consumers about digestive health, fostering informed purchasing choices.
   
• Given these dynamics, the U.S. is poised to maintain its dominance in the market, steering both growth and innovation.
   

Germany is on the brink of significant growth in the global digestive & intestinal remedies market landscape.
 

• With an aging demographic, Germany is witnessing a surge in digestive ailments—like acid reflux, constipation, and irritable bowel syndrome (IBS)—fueling demand for both OTC and prescription solutions.
   
• German consumers' inclination towards natural and organic digestive solutions mirrors the nation's broader cultural commitment to natural health and sustainability. This is further amplified by a burgeoning market for functional beverages, especially those enriched with probiotics or fiber.
   
• Germany's rigorous regulatory framework, especially concerning health products, bolsters consumer confidence in the safety and efficacy of digestive remedies, notably in the OTC and natural segments.
   
• The digital transformation of Germany's healthcare landscape has spurred a notable uptick in online sales of digestive remedies, a trend accelerated by the COVID-19 pandemic's push towards online shopping for safety and convenience.
   

The Asia Pacific region is set to experience a robust growth trajectory in the digestive & intestinal remedies market, with a projected CAGR of 4.2% during the analysis period.
 

• Factors like rapid urbanization, evolving dietary habits, and sedentary lifestyles are leading to a surge in digestive disorders—such as acid reflux, constipation, and irritable bowel syndrome (IBS)—across the Asia-Pacific. The region's rising consumption of processed foods, spicy cuisines, and erratic eating schedules further exacerbates these digestive challenges.
   
• As a response, there's a swift expansion of the OTC digestive remedies market, with pharmacies and supermarkets increasingly offering a diverse array of products to cater to these common issues.
   
• Additionally, factors like rising healthcare spending, a growing inclination towards self-medication, an aging demographic, and dietary influences are driving the market's upward trajectory.
   

Digestive & Intestinal Remedies Market Share

The competitive landscape in the market is driven by presence of diverse companies’ multinational corporations as well as regional and local players. Companies are presently focusing on developing advanced formulations with longer-lasting effects, fewer side effects, and improved efficacy. They are heavily investing in research and development to introduce new products, such as advanced probiotics, specialized supplements, and natural remedies, to cater to evolving consumer demands. Established brands with a history of effectiveness and safety enjoy strong consumer loyalty, making it challenging for new entrants to gain market share.
 

Digestive & Intestinal Remedies Market Companies

Prominent players operating in the digestive & intestinal remedies industry include:

• Abbott Laboratories
• Bayer AG
• C.H. Boehringer Sohn AG & Co. KG.
• China Resources Pharmaceutical Group Limited
• Eli Lilly and Company
• GlaxoSmithKline plc
• Johnson & Johnson
• Menarini Group
• Merck & Co, Inc.
• Pfizer Inc.
• The Procter & Gamble Company
• Reckitt Benckiser Group plc (RB)
• Sanofi S.A.
• Taisho Pharmaceutical Holdings Co., Ltd.
• Takeda Pharmaceutical Company Limited
   

Digestive & Intestinal Remedies Industry News:

• In October 2023, Pfizer received U.S. FDA approval for Velsipity, which is selective sphingosine-1-phosphate receptor modulator taken orally. The oral pill aimed at treating adult patients with moderately to severely active ulcerative colitis highlights Pfizer’s commitment towards new product development and positions itself as a strong competitor in the market.
   

The digestive & intestinal remedies market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Digestive medicines
• Remedies against gastrointestinal complaints
• Natural and synthetic agents

Market, By Age Group

• Adult
• Pediatric

Market, By Distribution Channel

• Offline
• Online

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa